Premium
CLINICAL TRIAL OF THE TOPICAL USE OF DISODIUM CROMOGLYCATE IN VERNAL, ALLERGIC AND CHRONIC CONJUNCTIVITIS
Author(s) -
LEINO MARKKU,
TUOVINEN ERKKI
Publication year - 1980
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.1980.tb04574.x
Subject(s) - disodium cromoglycate , allergic conjunctivitis , medicine , dermatology , vernal keratoconjunctivitis , etiology , sodium cromoglycate , asthma , immunology
Thirty‐three patients were treated with disodium cromoglycate (DSCG). Of these 5 had vernal conjunctivitis, 18 had allergic conjunctivitis and 10 had mild chronic conjunctivitis in which the exact aetiology could not be determined. 70% of patients with DSCG as the only medication achieved at least some beneficial effect being almost exlusively in the groups of either vernal or allergic conjunctivitis. The basic trend seemed to indicate a reduction in severity during the treatment with DSCG in allergic diseases.—